menu ☰
menu ˟

FDA clears Fujirebio PCT assay

13 Jun 2018
Fujirebio Diagnostics has received FDA clearance for a new procalcitonin, or PCT, assay to be used on its Lumipulse G1200 immunoassay platform, the company announced.According to the announcement, when used in conjunction with other laboratory findin...

Click here to view the full article which appeared in Nursing

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.